{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:48:50Z","timestamp":1792586930816,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:39:39Z","timestamp":1776829179000},"page":"685-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of FAPI PET\/CT in the Assessment of Inflammatory Diseases"],"prefix":"10.1053","volume":"56","author":[{"given":"Elnaz","family":"Jenabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Atzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-0813","authenticated-orcid":false,"given":"Matthieu","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pirich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Kuwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-3812","authenticated-orcid":false,"given":"Mohsen","family":"Beheshti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","volume":"51","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0002","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","article-title":"FAPI-Avid Non malignant PET\/CT Findings: An Expedited Systematic Review","volume":"53","author":"Bentestuen","year":"2023","journal-title":"Semin Nucl. Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0003","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer cell"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0004","article-title":"FAPI-PET\/CT in cancer imaging: a potential novel molecule of the century","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.124.268376","article-title":"Targeting fibroblast activation protein for molecular imaging of fibrotic remodeling in pulmonary arterial hypertension","volume":"66","author":"Hou","year":"2025","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ph19010089","article-title":"Radiolabelled FAPI radiotracers in oncology: a comprehensive review of current diagnostic and emerging therapeutic applications","volume":"19","author":"Czuczejko","year":"2026","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0007","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","article-title":"Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an 18F-labeled FAP inhibitor","volume":"61","author":"Toms","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0008","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2967\/jnumed.120.244806","article-title":"The latest developments in imaging of fibroblast activation protein","volume":"62","author":"Altmann","year":"2021","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0009","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3390\/diagnostics13122018","article-title":"FAPI PET\/CT imaging\u2014an updated review","volume":"13","author":"Chandekar","year":"2023","journal-title":"Diagnostics"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0011","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/ph17060716","article-title":"The role of fibroblast activation protein inhibitor positron emission tomography in inflammatory and infectious diseases: an updated systematic review","volume":"17","author":"Albano","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4\u20135","key":"10.1053\/j.semnuclmed.2026.04.003_bib0012","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.782231","article-title":"Clinical significance of diffusely increased uptake of 68Ga-FAPI in thyroid gland","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.04.003_bib0014","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/RLU.0000000000003637","article-title":"68Ga-FAPI uptake of thyroiditis in a patient with breast cancer","volume":"46","author":"Can","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12020-021-02605-4","article-title":"68Ga-FAPI PET\/CT imaging in a patient with thyroiditis","volume":"73","author":"Zhou","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0016","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-024-01129-y","article-title":"68Ga] Ga-FAPI versus 2-[18F] FDG PET\/CT in patients with autoimmune thyroiditis: a case control study","volume":"14","author":"Pabst","year":"2024","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/RLU.0000000000006175","article-title":"FAPI PET in the diagnosis and management of inflammatory diseases: clinical value and future perspectives","volume":"51","author":"Zhou","year":"2026","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0019","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1007\/s00259-021-05373-5","article-title":"68Ga-FAPI-46 and 18F-FDG PET\/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors","volume":"48","author":"Hotta","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/thy.2018.0116","article-title":"Immune-related thyroiditis with immune checkpoint inhibitors","volume":"28","author":"Iyer","year":"2018","journal-title":"Thyroid"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0021","doi-asserted-by":"crossref","first-page":"e250200","DOI":"10.1530\/ETJ-25-0200","article-title":"Unravelling the pathogenic mechanisms in Graves' orbitopathy","volume":"14","author":"Lee","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0022","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur j endocrinol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-021-02962-0","article-title":"A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by 68Ga-FAPI PET\/CT","volume":"76","author":"Rao","year":"2022","journal-title":"Endocrine"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0024","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/RLU.0000000000006081","article-title":"68Ga-FAPI PET\/MR for active thyroid eye disease following thyroidectomy: a case supporting its dual role in clinical management","volume":"50","author":"Zhou","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/RLU.0000000000005770","article-title":"Clinical Application of 68 Ga-Pentixafor PET\/CT for the Detection of Thymoma: A Pilot Study","volume":"50","author":"Wang","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","article-title":"Emerging molecular imaging targets and tools for myocardial fibrosis detection","volume":"24","author":"Barton","year":"2023","journal-title":"Eur Heart J-Cardiovasc Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20250110","article-title":"Recent implications of FAPI PET in cardiac diseases","volume":"6","author":"Wang","year":"2025","journal-title":"View"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0028","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1097\/RLU.0000000000005214","article-title":"Intense 68Ga-OncoFAP uptake as a new promising diagnostic biomarker in cardiac sarcoidosis","volume":"49","author":"Ventura","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0029","doi-asserted-by":"crossref","first-page":"ytac005","DOI":"10.1093\/ehjcr\/ytac005","article-title":"Cardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography\u2013magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis","volume":"6","author":"Siebermair","year":"2022","journal-title":"Eur Heart J-Case Rep"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00259-022-05994-4","article-title":"68Ga-FAPI PET visualize heart failure: from mechanism to clinic","volume":"50","author":"Song","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0031","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/acs.molpharmaceut.3c00075","article-title":"Visualization of activated fibroblasts in heart failure with preserved ejection fraction with [18F] AlF-NOTA-FAPI-04 PET\/CT imaging","volume":"20","author":"Sun","year":"2023","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0032","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12350-020-02315-w","article-title":"Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography","volume":"29","author":"Shi","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0033","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s12350-021-02646-2","article-title":"Diffuse uptake of [68Ga] Ga-FAPI in the left heart in a patient with hypertensive heart disease by PET\/CT","volume":"29","author":"Lin","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00259-024-06878-5","article-title":"Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga] Ga-FAPI-04 PET\/CMR imaging","volume":"52","author":"Ding","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00259-023-06411-0","article-title":"Functional significance of myocardial activity at 18F-FAPI PET\/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis","volume":"51","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","article-title":"Myocardial remodeling after infarction: the role of myofibroblasts","volume":"7","author":"Van Den Borne","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0037","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2967\/jnumed.119.226993","article-title":"Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04","volume":"60","author":"Varasteh","year":"2019","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0038","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/acs.molpharmaceut.2c00551","article-title":"Noninvasive monitoring of reparative fibrosis after myocardial infarction in rats using 68Ga-FAPI-04 PET\/CT","volume":"19","author":"Qiao","year":"2022","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0039","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","article-title":"Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET","volume":"46","author":"Kessler","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.04.003_bib0041","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","article-title":"Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging","volume":"49","author":"Xie","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0042","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","article-title":"[68Ga] Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0043","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s12350-021-02603-z","article-title":"Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04","volume":"29","author":"Notohamiprodjo","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0044","article-title":"Delayed 68Ga-FAPI-46 PET\/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction","volume":"50","author":"Kupusovic","year":"2024","journal-title":"IJC Heart Vasc"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-025-01246-2","article-title":"Evaluation of myocardial fibrosis and wall motion abnormality with 68Ga-FAPI PET\/MR in coronary heart disease","volume":"15","author":"Luo","year":"2025","journal-title":"EJNMMI Res"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0046","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/RLU.0000000000005380","article-title":"99mTc-PYP and 68Ga-FAPI PET\/CT images of hereditary transthyretin amyloidosis with cardiac involvement","volume":"49","author":"Kibar","year":"2024","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0047","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1148\/radiol.211951","article-title":"68Ga FAPI PET\/MRI in cardiac amyloidosis","volume":"303","author":"Guo","year":"2022","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0048","first-page":"1960","article-title":"Feasibility of 68Ga-labeled fibroblast activation protein inhibitor PET\/CT in light-chain cardiac amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"Cardiovasc Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0049","first-page":"323","article-title":"Molecular stratification of light-chain cardiac amyloidosis with 18F-Florbetapir and 68Ga-FAPI-04 for enhanced prognostic precision","volume":"18","author":"Wang","year":"2025","journal-title":"Cardiovasc Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.04.003_bib0050","first-page":"811","article-title":"FAPI PET imaging supports clinical decision making in academic cardiology practice: a pictorial imaging vignette","volume":"17","author":"Settelmeier","year":"2024","journal-title":"Cardiovasc Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0051","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/eurheartj\/ehz736","article-title":"Cardiac fibroblast activation detected by positron emission tomography\/computed tomography as a possible sign of cardiotoxicity","volume":"41","author":"Totzeck","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0052","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circ: Cardiovasc Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.04.003_bib0053","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s00259-024-06673-2","article-title":"Early detection of anthracycline-induced cardiotoxicity using [68 Ga] Ga-FAPI-04 imaging","volume":"51","author":"Wei","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0054","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-022-05962-y","article-title":"Early detection of radiation-induced myocardial damage by [18F] AlF-NOTA-FAPI-04 PET\/CT imaging","volume":"50","author":"Wei","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0056","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"35","key":"10.1053\/j.semnuclmed.2026.04.003_bib0057","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European society of cardiology working group on myocardial and pericardial disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0058","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/RLU.0000000000004767","article-title":"Displays of 18F-FAPI PET\/CT in myocarditis with variable symptom durations","volume":"48","author":"Zhou","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of checkpoint inhibitor-associated myocarditis using 68Ga-FAPI PET\/CT","volume":"8","author":"Finke","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.04.003_bib0060","first-page":"894","article-title":"Imaging immune checkpoint inhibitor myocarditis: can we do better?","volume":"7","author":"Doris","year":"2025","journal-title":"Cardio Oncol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0061","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00259-024-06986-2","article-title":"Comparison of [18F] FAPI-42 and [18F] FDG PET\/CT in the evaluation of systemic vasculitis","volume":"52","author":"Zhong","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0062","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000003692","article-title":"68Ga-FAPI PET\/CT versus 18F-FDG PET\/CT for the evaluation of disease activity in takayasu arteritis","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0063","first-page":"1097","article-title":"Intracranial and extracranial vascular involvement in Takayasu arteritis unresponsive to multiple lines of immunomodulation on 68Ga-FAPI PET\/CT: a game changer","volume":"10","author":"Kumar","year":"2022","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0064","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/rheumatology\/keae225","article-title":"Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission","volume":"63","author":"R\u00f6hrich","year":"2024","journal-title":"Rheumatology"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcmg.2025.09.020","article-title":"Molecular imaging of fibroblast activation protein on PET\/MRI: association with carotid-ulcerated plaques and cerebrovascular risk factors","volume":"19","author":"Fu","year":"2026","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0066","first-page":"79","article-title":"Molecular imaging of fibroblast activation protein on PET\/MRI: association with carotid-ulcerated plaques and cerebrovascular risk factors","volume":"19","author":"Fu","year":"2026","journal-title":"Cardiovasc Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0067","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11307-024-01919-9","article-title":"Molecular imaging of fibroblast activation in rabbit atherosclerotic plaques: a preclinical PET\/CT study","volume":"26","author":"Ji","year":"2024","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0068","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0069","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","article-title":"Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis","volume":"37","author":"Acharya","year":"2006","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0070","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10529-015-1855-8","article-title":"Luciferase expression is driven by the promoter of fibroblast activation protein-\u03b1 in murine pulmonary fibrosis","volume":"37","author":"Wenlong","year":"2015","journal-title":"Biotechnol Lett"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0071","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","article-title":"Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis","volume":"809","author":"Egger","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0072","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2967\/jnumed.124.268351","article-title":"Correlation of FAPI PET uptake with immunohistochemistry in explanted lungs from patients with advanced interstitial lung disease","volume":"65","author":"Hotta","year":"2024","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0073","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases","volume":"207","author":"Yang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0074","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1440-1843.2012.02272.x","article-title":"Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia","volume":"18","author":"Harada","year":"2013","journal-title":"Respirology"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm.164.6.2001056","article-title":"Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality","volume":"164","author":"KING JR","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0076","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study","volume":"3","author":"Bergmann","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0077","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12931-025-03367-7","article-title":"Pilot study of 18F-FAPI-RGD PET\/CT for the diagnosis of connective tissue disease associated interstitial lung disease","volume":"26","author":"Liu","year":"2025","journal-title":"Respir Res"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102598","article-title":"FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study","volume":"72","author":"Kastrati","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0079","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00259-025-07735-9","article-title":"Predicting the unpredictable: prognostic and predictive power of FAPI-PET imaging in oncology: a systematic review and meta-analysis","volume":"53","author":"Sadeghpour","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0080","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/jcm8091469","article-title":"High-resolution CT change over time in patients with idiopathic pulmonary fibrosis on antifibrotic treatment","volume":"8","author":"Balestro","year":"2019","journal-title":"J Clin Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0081","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00296-025-05934-z","article-title":"The association of symptoms, pulmonary function test and computed tomography in interstitial lung disease at the onset of connective tissue disease: an observational study with artificial intelligence analysis of high-resolution computed tomography","volume":"45","author":"Hoffmann","year":"2025","journal-title":"Rheumatol Int"},{"issue":"supplement 1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0082","article-title":"Emerging role of FAPI-PET\/CT in the imaging of interstitial Lung diseases","volume":"66","author":"Bhattarai","year":"2025","journal-title":"Soc Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0083","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"A primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0084","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"10.1053\/j.semnuclmed.2026.04.003_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214139","article-title":"Serum biomarkers of renal fibrosis: a systematic review","volume":"23","author":"Barinotti","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0086","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [68Ga] Ga-FAPI-04 imaging in the diagnosis of renal fibrosis","volume":"48","author":"Zhou","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0087","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1646412","article-title":"Advancements in the non-invasive diagnosis of renal fibrosis","volume":"12","author":"Yuan","year":"2025","journal-title":"Front Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0088","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05660-1","article-title":"[68 Ga] Ga-FAPI uptake correlates with the state of chronic kidney disease","volume":"49","author":"Conen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0089","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.semnuclmed.2026.01.001","article-title":"Can FAPI-PET imaging address unmet needs in nephro-urology?","volume":"56","author":"Pandya","year":"2026","journal-title":"Semin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0091","doi-asserted-by":"crossref","first-page":"sfae064","DOI":"10.1093\/ckj\/sfae064","article-title":"[18F] AlF-NOTA-FAPI-04 PET\/CT for non-invasive assessment of tubular injury in kidney diseases","volume":"17","author":"Wang","year":"2024","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0092","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.kint.2024.07.015","article-title":"Dynamically visualizing profibrotic maladaptive repair after acute kidney injury by fibroblast activation protein imaging","volume":"106","author":"Huang","year":"2024","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.04.003_bib0093","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40265-022-01715-1","article-title":"Lupus nephritis: improving treatment options","volume":"82","author":"Kostopoulou","year":"2022","journal-title":"Drugs"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0094","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1093\/rheumatology\/keae226","article-title":"Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis","volume":"63","author":"Sun","year":"2024","journal-title":"Rheumatology"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0095","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2967\/jnumed.124.268643","article-title":"68Ga-FAPI-04 PET\/CT imaging for assessing renal tubulointerstitial fibrosis in Lupus nephritis","volume":"66","author":"Yu","year":"2025","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0096","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00259-025-07523-5","article-title":"[18F]F-FAPI PET\/CT outperforms [18F]F-FDG PET\/CT in predicting treatment response in lupus nephritis","volume":"53","author":"Zhao","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.04.003_bib0097","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/annrheumdis-2021-221761","article-title":"Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis","volume":"81","author":"Floudas","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0098","first-page":"2243","article-title":"Recent advances in nuclear medicine and their role in inflammatory arthritis: focus on the emerg-ing role of FAPI PET\/CT","volume":"54","author":"Schmidkonz","year":"2024","journal-title":"SkeletRadiol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0099","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cpet.2014.07.002","article-title":"FDG-PET\/CT in infectious and inflammatory diseases","volume":"9","author":"Hess","year":"2014","journal-title":"PET Clin"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.23736\/S1824-4785.22.03461-6","article-title":"18F]FDG PET\/CT in rheumatoid arthritis","volume":"66","author":"Graham","year":"2022","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0102","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00256-024-04834-w","article-title":"Recent advances in nuclear medicine and their role in inflammatory arthritis: focus on the emerging role of FAPI PET\/CT","volume":"54","author":"Schmidkonz","year":"2025","journal-title":"Skelet Radiol"},{"issue":"1142","key":"10.1053\/j.semnuclmed.2026.04.003_bib0103","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","volume":"96","author":"Hotta","year":"2023","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0104","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222052","article-title":"(68)Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study","volume":"307","author":"Luo","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13550-023-01064-4","article-title":"[(68) Ga]Ga-FAPI-04 PET\/CT may be a predictor for early treatment response in rheumatoid arthritis","volume":"14","author":"Pan","year":"2024","journal-title":"EJNMMI Res"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0106","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005775","article-title":"Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease","volume":"11","author":"Atzinger","year":"2025","journal-title":"RMD Open"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0107","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41590-024-01774-4","article-title":"CD200(+) fibroblasts form a pro-resolving mesenchymal network in arthritis","volume":"25","author":"Rauber","year":"2024","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0108","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004294","article-title":"Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis","volume":"10","author":"Corte","year":"2024","journal-title":"RMD Open"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0109","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1007\/s00259-025-07310-2","article-title":"Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI-46 for evaluation of structural damage and inflammation in axial spondyloarthritis: a prospective study","volume":"52","author":"Chen","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.04.003_bib0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","article-title":"Global prevalence of advanced liver fibrosis and cirrhosis in the general population: a systematic review and meta-analysis","volume":"23","author":"Zamani","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0111","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","article-title":"Liver biopsy for assessment of chronic liver diseases: a synopsis","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Clin Exp Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0112","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc19-1071","article-title":"Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes","volume":"43","author":"Bril","year":"2020","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0113","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/diagnostics10110940","article-title":"Diagnostic accuracy of FibroScan and factors affecting measurements","volume":"10","author":"Oeda","year":"2020","journal-title":"Diagnostics"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0114","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","article-title":"The role of fibroblast activation protein in health and malignancy","volume":"39","author":"Fitzgerald","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0115","first-page":"1","article-title":"Fibroblast activation protein in liver fibrosis","volume":"24","author":"Lay","year":"2019","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.04.003_bib0116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12149-025-02027-6","article-title":"Efficacy of [68Ga] Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis","volume":"39","author":"Mori","year":"2025","journal-title":"Ann Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0117","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2967\/jnumed.121.263736","article-title":"Staging liver fibrosis by fibroblast activation protein inhibitor PET in a human-sized swine model","volume":"63","author":"Pirasteh","year":"2022","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0118","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1038\/s41598-025-34877-5","article-title":"A pilot human-based study of 68Ga-FAPI-04 PET\/CT in staging liver fibrosis and preliminary comparison to FIB-4 and fibroscan","volume":"16","author":"Li","year":"2026","journal-title":"Sci Rep"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0120","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1007\/s00259-024-06773-z","article-title":"Non-invasive visualization of liver fibrosis with [68Ga] Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation","volume":"51","author":"Song","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"14","key":"10.1053\/j.semnuclmed.2026.04.003_bib0121","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.3390\/ijms22147348","article-title":"Recent progress in the molecular imaging of nonalcoholic fatty liver disease","volume":"22","author":"Wegrzyniak","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0122","doi-asserted-by":"crossref","first-page":"236","DOI":"10.35248\/2167-0889.19.8.236","article-title":"Liver fibrosis conventional and molecular imaging diagnosis update","volume":"8","author":"Li","year":"2019","journal-title":"J Liver"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0123","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/03009734.2013.872736","article-title":"Endothelial dysfunction in patients with non-alcoholic steatohepatitis","volume":"119","author":"Onal","year":"2014","journal-title":"Upsala J Med Sci"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0124","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.04.003_bib0125","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1016\/j.acra.2025.07.034","article-title":"Beyond cancer: the role of radiolabeled fibroblast activation protein inhibitors (FAPI) in non-oncological molecular imaging","volume":"32","author":"Jafari","year":"2025","journal-title":"Acad Radiol"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0126","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1021\/acsptsci.4c00641","article-title":"Fibroblast activation protein inhibitor (FAPI)-radioligand PET\/CT in the assessment of nononcological diseases: a narrative review","volume":"8","author":"Kalantari","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0127","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with 68Ga-FAPI PET\/MR enterography in Crohn disease","volume":"307","author":"Scharitzer","year":"2023","journal-title":"Radiology"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.04.003_bib0128","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00259-025-07608-1","article-title":"Diagnostic utility of FDG and FAPI PET imaging in crohn\u2019s disease: a systematic review and meta-analysis","volume":"53","author":"Abdlkadir","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0129","first-page":"1","article-title":"Discrimination between inflammatory and fibrotic activity in Crohn\u2019s disease-associated ileal-colonic anastomotic strictures by combined Ga-68-FAPI-46 and F-18-FDG-PET\/CT imaging","volume":"41","author":"Beck","year":"2025","journal-title":"Visc Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0130","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-023-06107-5","article-title":"68Ga] Ga-FAPI-04 PET\/CT on assessing Crohn\u2019s disease intestinal lesions","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0131","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-020-05129-7","article-title":"Active uptake of 68Ga-FAPI in Crohn\u2019s disease but not in ulcerative colitis","volume":"48","author":"Luo","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"supplement 2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0132","article-title":"68Ga-FAPI PET\/CT for non-invasive characterization of ulcerative colitis and Crohn's disease","volume":"65","author":"Debus","year":"2024","journal-title":"Soc Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0133","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/ibd.21446","article-title":"Fibroblast activation protein expression in Crohn's disease strictures","volume":"17","author":"Rovedatti","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.04.003_bib0134","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1007\/s00259-025-07686-1","article-title":"68Ga-FAPI PET\/CT for non-invasive characterization and activity assessment of ulcerative colitis and Crohns disease","volume":"53","author":"Debus","year":"2026","journal-title":"Eur J Nuc Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.04.003_bib0135","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","article-title":"Management of IgG4-related disease","volume":"1","author":"Zhang","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0136","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","article-title":"Clinical perspectives on IgG4-related disease and its classification","volume":"73","author":"Katz","year":"2022","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.04.003_bib0137","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein\u2013targeted PET\/CT with 68Ga-FAPI for imaging IgG4-related disease: comparison to 18F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.04.003_bib0138","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2967\/jnumed.124.268943","article-title":"Differences in fibroinflammatory activity shown on 68Ga-FAPI-04 and 18F-FDG PET\/CT in the two subtypes of IgG4-related disease","volume":"66","author":"Liu","year":"2025","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.04.003_bib0139","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/RLU.0000000000004793","article-title":"Serial 68Ga-FAPI PET\/CT after treatment of immunoglobulin G4-related pancreatitis and retroperitoneal fibrosis","volume":"48","author":"Cho","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.04.003_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.1038797","article-title":"The different manifestations of 18F-FDG PET\/CT and 68Ga-FAPI-04 PET\/CT in evaluation of the steroid therapy response for IgG4-related disease: a case report","volume":"2","author":"Jia","year":"2023","journal-title":"Front Nucl Med"},{"issue":"12","key":"10.1053\/j.semnuclmed.2026.04.003_bib0141","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00259-019-04478-2","article-title":"IgG4-related disease revealed by 68Ga-FAPI and 18F-FDG PET\/CT","volume":"46","author":"Luo","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:31:43Z","timestamp":1792585903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826000851"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.04.003","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of FAPI PET\/CT in the Assessment of Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}